Oncology company Boundless Bio (BOLD) announced Monday that Jami Rubin has stepped down from her role as Chief Financial Officer (CFO) for personal reasons.
Boundless Bio does not currently plan to hire a successor CFO at this time. The company said David Hinkle, Senior Vice President, Finance and Controller, will maintain responsibility for the company's Finance operations and assume the roles of principal financial and accounting officer.
Hinkle has served as Vice President, Finance and Controller of Boundless Bio since June 2021. He has a wealth of financial and technical accounting knowledge and experience stemming from over 25 years in the industry.
Prior to Boundless, Hinkle served as Vice President, Finance and Controller at Crinetics Pharmaceuticals. He also served in similar capacities at Ignyta, Receptos, Somaxon Pharmaceuticals and Digirad. He began his career at Deloitte.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.